Before you can access ASH's online program, you must agree to the following:
Last updated January 16, 2009. Please note that this site represents the latest program changes
and differs from the print version in some details.

High-Risk Myeloma

Saturday, December 6, 2008: 2:00 PM-3:30 PM
304-306-308 - South (Moscone Center)
Sunday, December 7, 2008: 7:30 AM-9:00 AM
304-306-308 - South (Moscone Center)
Genetic Origin of Myeloma

Marta Chesi1*, Peter Leif Bergsagel, MD1 and Michael Kuehl, MD2*

1Mayo Clinic, Scottsdale, AZ
2Genetics Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD

Molecular Indicators of High-Risk Disease

John D. Shaughnessy Jr., PhD1 and Bart Barlogie2*

1Myeloma Inst./Lambert Lab. of Myeloma, University of Arkansas for Medical Sciences, Little Rock, AR
2Myeloma Institute for Research and Therapy, University of Arkansas for Medical Science, Little Rock, AR

Influence of Targeted Therapy in Redefining High-Risk Myeloma

Lori Hazlehurst, PhD1*, William S. Dalton, MD, PhD1, Danielle Yarde1*, Yulia Nefedova, MD, PhD2 and Dmitry Gabrilovich1*

1H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
2H. Lee Moffitt Cancer Center, Tampa, FL

See more of: Scientific Program